 |
$1000 Genome: Exploring Personalized Medicine
Program Features Renowned Genome
Researcher, Dr. Chad Nusbaum
Wednesday, September 24
7:00 a.m. - 9:00 a.m.
Peabody Marriott
Cost: $25 for NSTC members, $45 for non-members
Because there is a limited capacity for this event, we recommend advanced registration. Register online now and reserve your seat today! Registration, networking and continental breakfast from 7:00 a.m. - 7:45 a.m. with the presentation and Q&A from 7:45 a.m. - 9:00 a.m.
Program Description
When the U.S. Human Genome Project announced in 1991 the successful sequencing of the human genome, the 13-year project reportedly cost $3 billion. In contrast, experts today predict that in the near future sequencing an individual's genome will cost as little as $1000.
While the U.S. Human Genome Project is already impacting medicine, the $1000 genome will accelerate change by giving health practitioners the means to deliver truly personalized treatment.
At this breakfast, Dr. Chad Nusbaum, the co-director of the genome sequencing and analysis program at the world-renowned Broad Institute will explore the history and the motivation behind the quest for the $1000 genome. Additionally, Dr. Nusbaum will describe the amazing strides in sequencing technology that put this goal within reach along with some current and pending applications of the technology.
The Broad Institute is a research collaboration of MIT, Harvard and its affiliated hospitals, and the Whitehead Institute, created to bring the power of genomics to medicine.
Speaker:
Chad Nusbaum is co-director of the genome sequencing and analysis program at the Broad Institute. He leads the institute's maize and Phytophthora infestans (potato blight) genome projects. He oversees a variety of technology development projects, as well as several microbial and fungal genome projects. In addition, he plays a leading role in the Broad Institute's vertebrate genome projects.
In 1996, Chad joined the Whitehead Institute/MIT Center for Genome Research, now part of the Broad Institute, as a research scientist involved in the creation of genome-wide maps for human and mouse. In 1997, he joined the pilot project for human genome sequencing that pioneered high-throughput methods for large-scale sequencing and was responsible for building and leading the sequence-finishing team.
In 2001, he became co-director of the genome sequencing and analysis program and, together with Bruce Birren, managed the center's contribution to the sequencing of the human genome.
Chad received his Ph.D. in biology from MIT, studying sex determination and X-chromosome-linked gene expression in the nematode Caenorhabditis elegans. He completed his postdoctoral training in plant genetics at the University of California, Berkeley. Prior to joining the Whitehead Institute, he was the project leader on a gene mapping project for type I diabetes at Mercator Genetics, Inc.
Sponsored by:
Take Action!
Programs
